Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
92 2nd Street
Hackensack, NJ 07601Phone+1 551-996-3925Fax+1 201-662-1267- Is this information wrong?
Summary
- Stuart Goldberg MD currently serves as the Chief, Division of Outcomes and Value Research at the John Theurer Cancer Center, and previously was a Chief Division of Leukemia and Member of the Center's Bone Marrow Transplant Program. He is involved in the clinical care of patients with Acute and Chronic Leukemia, MDS and other bone marrow failure diseases. The program is an MDS Foundation Center of Excellence (and serves on the MDS Foundations Development Board), and Dr Goldberg is a medical advisor to the NJ Leukemia Society. He is the principal investigator of over 30 active trials and currently an international co-chair on the SIMPLICTY CML trial. Dr Goldberg lectures extensively on various topics and has discussed the role of chelation therapy in MDS on 5 different continents. Dr Goldberg also served as the Chief Medical Officer of COTA Inc, a medical data and analytics company founded at the John Theurer Cancer Center. COTA seeks to find value in healthcare.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1991 - 1992
- George Washington UniversityFellowship, Hematology and Medical Oncology, 1989 - 1991
- George Washington UniversityResidency, Internal Medicine, 1986 - 1989
- Pennsylvania State University College of MedicineClass of 1986
Certifications & Licensure
- NJ State Medical License 1998 - 2025
- DC State Medical License 2019 - 2020
- PA State Medical License 1989 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- David King Clinical Scientist Award Association of Community Cancer Centers, 2016
- Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2015
- Inside Jersey Magazine Top Doctors Castle Connolly, 2012-2015
- Join now to see all
Clinical Trials
- Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients Start of enrollment: 2007 Dec 01
- Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML Start of enrollment: 2009 Oct 01
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
- Join now to see all
Publications & Presentations
PubMed
- Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients.Maram Almohaywi, Bruna M Sugita, Ariana Centa, Aline S Fonseca, Valquiria C Antunes, Paolo Fadda, Ciaran M Mannion, Tomilowo Abijo, Stuart L Goldberg, Michael C Campbe...> ;International Journal of Molecular Sciences. 2023 Aug 22
- Bariatric surgery and oral chemotherapy: Where is the dosing guidance?Stuart L Goldberg> ;Cancer. 2023 Jun 15
- 7 citationsTransplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.Geoffrey L Uy, Laura F Newell, Tara L Lin, Stuart L Goldberg, Matthew J Wieduwilt, Robert J Ryan, Stefan Faderl, Jeffrey E Lancet> ;Blood Advances. 2022 Sep 13
- Join now to see all
Journal Articles
- Phase 2b Study of Two Dosing Regimens of Quizartinib Monotherapy in FLT3-ITD Mutated, Relapsed or Refractory AMLAlexander E Perl, Mark J Levis, Stuart L Goldberg, Martin S Tallman, Hagop M Kantarjian, Gary J Schiller, Blood
Abstracts/Posters
- Blinatumomab in Combination with Tyrosine Kinase Inhibitors Safely and Effectively Induces Rapid, Deep, and Durable Molecular Responses in Relapsed and Refractory Phil...Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Evomela¬ Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell TransplantationStuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloi...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Dosing Patterns of Dasatinib Use in Simplicity, an Observational Study in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients (pts) in Routine Clinical Practice2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- New Model Can Help Clinicians to Predict 40-Day Mortality Risk in Hospitalized COVID-19 PatientsAugust 2nd, 2021
- Hope Dims for Hydroxychloroquine Even as Medical Study Detailing the Drug’s Failure Is RetractedJune 5th, 2020
- On the Front Lines During the First Wave of COVID-19 Pandemic: Hackensack Meridian Health PublishingJune 5th, 2020
- Join now to see all
Committees
- Development Board, Myelodysplastic Syndromes Foundation 2016 - Present
- Medical Advisory Board, Leukemia Society (NJ Chapter) 2002 - Present
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: